Pfizer has sued Ranbaxy Laboratories Ltd. in federal court in Delaware to block Ranbaxy's generic versions of Lipitor and Caduet until patents tied to the cholesterol drugs lapse in 2016. Ranbaxy, already barred from marketing copies of the medicines until 2010, declined to comment on the case.

Full Story:

Related Summaries